ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2020 American Transplant Congress

    Use of Direct Acting Antiviral Medications in Transplant Recipients Receiving Organs from Hepatitis C Viremic Donors

    S. Bova1, A. Cameron1, C. Durand1, J. Katzianer2, M. LeGrand2, L. Boyer1, J. Glorioso3, L. P. Toman1

    1The Johns Hopkins Hospital, Baltimore, MD, 2Johns Hopkins Home Care Group, Baltimore, MD, 3Thomas Jefferson Univeristy Hospital, Philadelphia, PA

    *Purpose: The availability and high efficacy of direct acting antivirals (DAAs) to treat hepatitis C (HCV) is changing practice in solid organ transplant. A large…
  • 2020 American Transplant Congress

    Donor Derived Transmissions 2018: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    M. Michaels1, B. Plucinski2, E. Ward2, L. Strasfeld1, M. Malinis1, C. Ho1, L. Danziger-Isakov1, J. Bucio1, G. Berry1, M. Rana1, C. Marboe1, S. Aslam1, R. Razonable1, S. Pouch1, G. F. Marklin1, J. Levitsky1, D. Levine1, A. Agarwal1, R. LaHoz1

    1OPTN DTAC, Richmond, VA, 2UNOS, Richmond, VA

    *Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
  • 2020 American Transplant Congress

    Outcomes in Liver Transplantation with Use of Granulocyte-Colony Stimulating Factor

    K. Schnelle, A. Leino, M. Chunduru, L. Von Stein, O. Witkowsky

    The Ohio State Wexner Medical Center, Columbus, OH

    *Purpose: Questions remain if treatment with a granulocyte-colony stimulating factor (G-CSF) impacts clinical outcomes after liver transplant. The purpose of this study was to compare…
  • 2020 American Transplant Congress

    Risk of Invasive Fungal Infection after Heart Transplantation

    Z. A. Yetmar1, B. Lahr2, E. Beam3

    1Department of Medicine, Mayo Clinic, Rochester, MN, 2Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, 3Division of Infectious Diseases, Mayo Clinic, Rochester, MN

    *Purpose: Invasive fungal infection (IFI) after heart transplantation is a feared complication associated with significant morbidity and mortality. Risk factors for invasive fungal infection after…
  • 2020 American Transplant Congress

    Preoperative Antibody Titer Against BK Polyomavirus May Predict BK Polyomavirus-Associated Nephropathy after Kidney Transplantation

    M. Saito, S. Satoh, K. Numakura, R. Sagehashi, R. Yamamoto, A. Koizumi, T. Nara, S. Narita, T. Habuchi

    Urology, Akita University Hospital, Akita, Japan

    *Purpose: BK polyomavirus (BKPyV) is a causative agent of BKPyV-associated nephropathy (BKPyV-AN) and hemorrhagic cystitis, which occurs subsequent to BKPyV reactivation. Intravenous immunoglobulin is presumed…
  • 2020 American Transplant Congress

    Incidence and Effects of Posttransplant Herpes Zoster in Adult Solid Organ Transplant Recipients : A Meta-Analysis

    S. H. Han, D. Kwon

    Yonsei University Health System, Seoul, Korea, Republic of

    *Purpose: Recently, non-live recombinant subunit HZ vaccine showed highly effective for herpes zoster (HZ) in hematopoietic stem cell transplantation. Several observational studies reported various features…
  • 2020 American Transplant Congress

    Outpatient Treatment of Paramyxovirus with Oral Ribavirin is Safe and Effective in Lung Transplant Recipients

    A. W. Rogers1, B. J. Pierce1, C. Pham1, J. T. Swan1, H. J. Huang2

    1Department of Pharmacy, Houston Methodist Hospital, Houston, TX, 2Department of Medicine, Houston Methodist Hospital, Houston, TX

    *Purpose: Respiratory paramyxovirus infections present an increased risk to lung transplant recipients (LTRs), including rapid decline in graft function and immunologic sequelae such as rejection…
  • 2020 American Transplant Congress

    Effectiveness and Tolerability of Cidofovir for the Management of BK Viremia in Kidney Transplant Recipients

    M. Thornberg1, J. Hedvat1, N. Lange1, C. Brennan2, D. Salerno1, D. Tsapepas2

    1NewYork-Presbyterian Hospital, Department of Pharmacy, New York, NY, 2Columbia Irving University Medical Center, Department of Transplant Surgery, New York, NY

    *Purpose: BK viremia (BKV) is a common complication after kidney transplantation (KT) that often leads to graft dysfunction and loss. Without consensus management guidelines and…
  • 2020 American Transplant Congress

    Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population

    S. Suh, Y. Choi

    Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of

    *Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…
  • 2020 American Transplant Congress

    Experience with a BKV-Specific, Neutralizing Monoclonal Antibody (MAU868) for Treatment of Severe BK Virus Nephropathy (BKVN) after Kidney Transplant (FDA EIND #139112)

    S. C. Jordan1, S. J. Kovacs2, J. R. Abend3, N. Ammerman1, M. Toyoda1, C. C. Nast1, E. Huang1, R. Najjar1, S. Sethi1, A. Peng1, K. Lim1, M. R. Hodges4, A. Vo1

    1Cedars Sinai Medical Ctr, Los Angeles, CA, 2Novartis Institutes for BioMedical Research, East Hanover, NJ, 3Novartis Institutes for BioMedical Research, Emeryville, CA, 4Amplyx Pharmaceuticals, San Diego, CA

    *Purpose: BK viral reactivation leading to nephropathy and allograft loss in kidney transplant recipients remains a significant challenge. No effective BKV-therapies are currently available. Management…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences